Dopamine in drug abuse and addiction: results of imaging studies and treatment implications
- PMID: 17998440
- DOI: 10.1001/archneur.64.11.1575
Dopamine in drug abuse and addiction: results of imaging studies and treatment implications
Abstract
Imaging studies have provided new insights on the role of dopamine (DA) in drug abuse and addiction in the human brain. These studies have shown that the reinforcing effects of drugs of abuse in human beings are contingent not just on DA increases per se in the striatum (including the nucleus accumbens) but on the rate of DA increases. The faster the increases, the more intense the reinforcing effects. They have also shown that elevated levels of DA in the dorsal striatum are involved in the motivation to procure the drug when the addicted subject is exposed to stimuli associated with the drug (conditioned stimuli). In contrast, long-term drug use seems to be associated with decreased DA function, as evidenced by reductions in D2 DA receptors and DA release in the striatum in addicted subjects. Moreover, the reductions in D2 DA receptors in the striatum are associated with reduced activity of the orbitofrontal cortex (region involved with salience attribution and motivation and with compulsive behaviors) and of the cingulate gyrus (region involved with inhibitory control and impulsivity), which implicates deregulation of frontal regions by DA in the loss of control and compulsive drug intake that characterizes addiction. Because DA cells fire in response to salient stimuli and facilitate conditioned learning, their activation by drugs will be experienced as highly salient, driving the motivation to take the drug and further strengthening conditioned learning and producing automatic behaviors (compulsions and habits).
Similar articles
-
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications.Mol Psychiatry. 2004 Jun;9(6):557-69. doi: 10.1038/sj.mp.4001507. Mol Psychiatry. 2004. PMID: 15098002 Review.
-
Imaging dopamine's role in drug abuse and addiction.Neuropharmacology. 2009;56 Suppl 1(Suppl 1):3-8. doi: 10.1016/j.neuropharm.2008.05.022. Epub 2008 Jun 3. Neuropharmacology. 2009. PMID: 18617195 Free PMC article. Review.
-
The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies.Neuropharmacology. 2004;47 Suppl 1:3-13. doi: 10.1016/j.neuropharm.2004.07.019. Neuropharmacology. 2004. PMID: 15464121 Review.
-
Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies.Neurobiol Learn Mem. 2002 Nov;78(3):610-24. doi: 10.1006/nlme.2002.4099. Neurobiol Learn Mem. 2002. PMID: 12559839
-
Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review.J Addict Dis. 2004;23(3):39-53. doi: 10.1300/J069v23n03_04. J Addict Dis. 2004. PMID: 15256343 Review.
Cited by
-
Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases.Front Neurosci. 2016 Oct 5;10:451. doi: 10.3389/fnins.2016.00451. eCollection 2016. Front Neurosci. 2016. PMID: 27761108 Free PMC article. Review.
-
Δ9-Tetrahydrocannabinol does not upregulate an aversive dopamine receptor mechanism in adolescent brain unlike in adults.Curr Res Neurobiol. 2023 Sep 4;5:100107. doi: 10.1016/j.crneur.2023.100107. eCollection 2023. Curr Res Neurobiol. 2023. PMID: 38020805 Free PMC article.
-
Chronic administration of the dopamine D2/3 agonist ropinirole invigorates performance of a rodent slot machine task, potentially indicative of less distractible or compulsive-like gambling behaviour.Psychopharmacology (Berl). 2017 Jan;234(1):137-153. doi: 10.1007/s00213-016-4447-y. Epub 2016 Oct 6. Psychopharmacology (Berl). 2017. PMID: 27714426
-
Gradient of Expression of Dopamine D2 Receptors Along the Dorso-Ventral Axis of the Hippocampus.Front Synaptic Neurosci. 2019 Oct 15;11:28. doi: 10.3389/fnsyn.2019.00028. eCollection 2019. Front Synaptic Neurosci. 2019. PMID: 31680927 Free PMC article.
-
Nucleus accumbens medium spiny neurons subtypes signal both reward and aversion.Mol Psychiatry. 2020 Dec;25(12):3241-3255. doi: 10.1038/s41380-019-0484-3. Epub 2019 Aug 28. Mol Psychiatry. 2020. PMID: 31462765 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical